TP53 and small cell lung carcinoma: Our study not only identified novel recurrent genetic alterations such as CDH10 and DNA repair pathways which may influence outcomes in SCLC patients, but also revealed SRSF1, an RNA-splicing factor which can form complexes with TP53 and Top1, and plays a critical role in SCLC patient survival.